A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients - Wikidata - awgldk - TriplyDB

A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients

A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients

http://www.wikidata.org/entity/Q34288828

about

Predicting outcome from dengue Extended Evaluation of Virological, Immunological and Pharmacokinetic Endpoints of CELADEN: A Randomized, Placebo-Controlled Trial of Celgosivir in Dengue Fever Patients Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome Recent advances in understanding dengue Chutes and ladders in hepatitis C nucleoside drug development Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment Genomic approaches for understanding dengue: insights from the virus, vector, and host Dengue: an update on treatment options An Evidence-Based Algorithm for Early Prognosis of Severe Dengue in the Outpatient Setting.Dengue therapeutics, chemoprophylaxis, and allied tools: state of the art and future directions Analysis of Dengue Virus Genetic Diversity during Human and Mosquito Infection Reveals Genetic Constraints Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond 18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response Current Status of Dengue Therapeutics Research and Development.Therapeutic Potential of Spirooxindoles as Antiviral Agents Therapeutics for dengue: recommendations for design and conduct of early-phase clinical trials.Antibody-dependent enhancement infection facilitates dengue virus-regulated signaling of IL-10 production in monocytes.Review article: Research on dengue during World War II revisited.Lovastatin delays infection and increases survival rates in AG129 mice infected with dengue virus serotype 2 Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.Discovery of Dengue Virus NS4B Inhibitors.Identification of dengue viral RNA-dependent RNA polymerase inhibitor using computational fragment-based approaches and molecular dynamics study.Modelling Virus and Antibody Dynamics during Dengue Virus Infection Suggests a Role for Antibody in Virus Clearance.Discovery and Validation of Prognostic Biomarker Models to Guide Triage among Adult Dengue Patients at Early Infection.LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets.Lovastatin for the Treatment of Adult Patients With Dengue: A Randomized, Double-Blind, Placebo-Controlled Trial Experimental therapies for yellow fever Host and viral features of human dengue cases shape the population of infected and infectious Aedes aegypti mosquitoes.A Novel Benzodiazepine Compound Inhibits Yellow Fever Virus Infection by Specifically Targeting NS4B Protein.Activation of peripheral blood mononuclear cells by dengue virus infection depotentiates balapiravir.West Nile virus drug discovery.Drugs for dengue: a patent review (2010-2014).Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.4'-Azidocytidine (R1479) inhibits henipaviruses and other paramyxoviruses with high potency.New developments in flavivirus drug discovery.Investigational drugs in early development for treating dengue infection.Synergistic suppression of dengue virus replication using a combination of nucleoside analogs and nucleoside synthesis inhibitors.A nuclear transport inhibitor that modulates the unfolded protein response and provides in vivo protection against lethal dengue virus infection.Current management of severe dengue infection.

P2860

Q21146686-CDD94114-8179-4F94-AD2C-B509BA43D57A Q26257542-F5C22FBB-14B1-4C36-AA4E-B14CDF16CDD4 Q26700454-FFE72244-CFF6-4D8C-94B1-BB336AE863A9 Q26766156-F3716513-8B65-462D-A6D0-0086E9EB9073 Q26998630-1089DD5B-BD5A-4F2D-A873-A99116CDB854 Q27010609-5C0D10A4-637C-4FAF-BACA-A4B2C67AED70 Q28073351-A4B1ECAA-F7C1-46A9-9F0B-61A7DA1E6A09 Q28085044-0C1E15BF-9122-4606-8096-DE156A9317B8 Q28114617-8A64DB26-A105-4C97-953E-A0E28FAAD552 Q28542607-0C8A1B8B-5F09-49EA-92F8-84F71A45B6E0 Q28547668-9205B132-3716-4FE9-B0D2-80E3E4459DF8 Q28550953-0C500A9E-E251-4387-B054-C506D015B188 Q29994527-D6261894-5905-411B-98F8-19F78DA05FF7 Q30250993-65012FF5-C2BC-4B64-96FB-CA5CAE569C46 Q33552896-6943A3F6-011F-42A8-BA10-D18C36966FBB Q33637160-7339F2E8-C0C9-448C-8E5F-B6D333269E25 Q34431491-3FD6DDFB-5D9E-4066-AED5-E704C94A4E38 Q34550268-6A5F7D3D-09FD-4F10-B68C-604458DC9C58 Q34640272-C7CF67E5-BF39-4610-A71B-3C77FAFB42E5 Q35105926-F95029D9-4F92-4542-83E6-6FBC2BCFE57E Q35274810-A00D93A2-4871-49DB-A5F9-241BB4DC7C87 Q35643850-5D6184AA-BD14-4D2F-A069-B015207C48E1 Q35742387-20F65575-6CCC-47B4-B79E-D8DA2E9E2A9F Q36026321-400C3933-6DA0-49DE-A686-A44D199729F0 Q36048467-887A546C-F744-402B-90C0-48BD73B70CAA Q36478122-89858765-CA13-418A-A82C-3BB6D824BE7B Q36497872-A321BFC8-E84D-4A91-80AE-643025E8BC0D Q36586306-27675B27-7A97-4249-B965-ACE17EF66F2B Q36895627-30863065-63F2-4FFB-8EF8-476F1068C728 Q37415438-0026ED09-9515-45CA-9C87-E932BF347698 Q37547347-6CDC1488-F55D-4946-977F-2EE00617550E Q37666750-637073DB-527D-49CE-BDA5-F3BA7B03A766 Q38256785-FFD8D3EF-C576-4D9F-8DBF-DAECBE1239F5 Q38665457-A8B3882C-3CA1-4E16-9C61-1D01082EB1DD Q38669158-6B25E553-7B00-4FF1-B6CB-4A09CAE45091 Q38769771-917ACF7C-B8CF-402F-8F03-3556A47A6972 Q38870485-7882C230-6CB7-4051-A7C3-4847166064CD Q38916167-696BC072-FFC6-4BAC-8840-4566711C9892 Q38987775-D1839C98-BCD1-49D8-BABD-5227EBE6EE92 Q38992396-79A924C0-C7C9-4DB5-83A2-DA5C719A4E41

P2860

A randomized, double-blind placebo controlled trial of balapiravir, a polymerase inhibitor, in adult dengue patients

http://www.wikidata.org/entity/Q34288828

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

A randomized, double-blind pla ...... itor, in adult dengue patients

@ast

A randomized, double-blind pla ...... itor, in adult dengue patients

@en

A randomized, double-blind pla ...... itor, in adult dengue patients

@nl

type

label

A randomized, double-blind pla ...... itor, in adult dengue patients

@ast

A randomized, double-blind pla ...... itor, in adult dengue patients

@en

A randomized, double-blind pla ...... itor, in adult dengue patients

@nl

prefLabel

A randomized, double-blind pla ...... itor, in adult dengue patients

@ast

A randomized, double-blind pla ...... itor, in adult dengue patients

@en

A randomized, double-blind pla ...... itor, in adult dengue patients

@nl

P1433

Q34288828-532482E5-0343-4B37-943C-27BB2AF6AB3F

P1476

Q34288828-4535B2CF-7D83-4752-8E2B-5C99AA3F24E4

P2093

Q34288828-024F29D9-1862-48D6-A714-2ED41CEE9C10

Q34288828-0C515516-0A0A-4B18-8B79-4303368CE694

Q34288828-0ECBADFD-5BA4-4A54-A77E-E938192A213F

Q34288828-10F60B0B-B968-416D-957B-22F17C71259D

Q34288828-15D7A32B-39AE-4633-9E53-F77379E1D3A6

Q34288828-2115FFB5-4A63-435C-8D3D-554AF863757D

Q34288828-219255C0-16AC-4507-A0B6-F61000472015

Q34288828-22A4773F-DF6A-439B-BE04-A30AE0E665FF

Q34288828-36CEC7B6-5E5C-45C6-B878-3DDACDC79219

Q34288828-6D59EA72-57DB-4BC5-8CBC-F85A0BFC5F36

P2860

Q34288828-04B3F6CC-D2BE-4388-AA8F-1AB9E2DB8D59

Q34288828-0B7B8B74-AC21-4D86-AD3B-5DDAFA7A0BEE

Q34288828-17B03254-8199-4296-B4B1-0E64B86B4B36

Q34288828-313C1EBC-221C-41B4-9439-A9552F0271C9

Q34288828-32B93CB0-B716-41EC-BE29-6C3A72C62715

Q34288828-36151BA7-11F0-4E6A-972D-192C8F387DEC

Q34288828-41C1E598-2F49-49EE-BBD6-CBD9BAFEBC90

Q34288828-4A99752E-A392-4ABB-8586-5C1E2EA673D1

Q34288828-7AF9F984-B4F1-4E0E-9167-94588398CDDF

Q34288828-92D0EE5B-C8F1-44B0-8A6C-3937692D75B7

P304

Q34288828-490C8709-B33C-4830-9F8E-AF13D6F47EAC

P31

Q34288828-D86146D0-1558-4D57-898C-D7A61A39E818

P356

Q34288828-592C0AE0-3C49-46BD-90A0-2DCD5DFD9674

P407

Q34288828-BC80EB85-E537-40A2-BA8E-41FBCF317B2C

P433

Q34288828-450703CE-44D0-41F2-8B25-2132871A761F

P478

Q34288828-0817A768-F365-4EAB-A57A-90CEB9A61310

P50

Q34288828-1483267C-6BC2-451D-B895-2D187DC6A20E

Q34288828-425CD2F5-2A86-4766-AA41-468D4ED2A886

Q34288828-99DDC81D-F875-40EF-9D21-7E41790091AB

Q34288828-B3C97250-93EC-43D4-A8E8-14AD719D9734

Q34288828-BFA75018-124F-4706-9291-4FCA9BE3B862

Q34288828-CB889B63-C383-4AB1-B427-071BB89421D5

P577

Q34288828-A146E65A-BBC8-453B-B848-C0AF5F726F34

P5875

Q34288828-3B70F76A-2E49-4409-8556-76C0877D8160

P698

Q34288828-8D3BECC2-4872-4094-8E65-6EBE579F572E

P921

Q34288828-104AF8C1-5BC4-4652-834D-1C23E555B1FD

Q34288828-F3EB0233-2C66-499D-B1D0-B01C533C5CE3

P932

Q34288828-B1F6CC58-BA85-4AEB-A22C-7E4A694E90D0

P356

P1433

The Journal of Infectious Diseases

P1476

A randomized, double-blind pla ...... itor, in adult dengue patients

@en

P2093

Chau Nguyen Bich Tran

http://www.w3.org/2001/XMLSchema#string

Chau Van Vinh Nguyen

http://www.w3.org/2001/XMLSchema#string

Chinh Tran Nguyen

http://www.w3.org/2001/XMLSchema#string

Dung Thi Nguyen

http://www.w3.org/2001/XMLSchema#string

Hassan Javanbakht

http://www.w3.org/2001/XMLSchema#string

Hien Tinh Tran

http://www.w3.org/2001/XMLSchema#string

Huy le Anh Huynh

http://www.w3.org/2001/XMLSchema#string

Janet Hammond

http://www.w3.org/2001/XMLSchema#string

Kien Thi Hue Duong

http://www.w3.org/2001/XMLSchema#string

Klaus Klumpp

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal Structure of the Dengue Virus RNA-Dependent RNA Polymerase Catalytic Domain at 1.85-Angstrom Resolution

An adenosine nucleoside inhibitor of dengue virus

Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity

A randomized controlled trial of chloroquine for the treatment of dengue in Vietnamese adults

High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever

Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections.

Strategies for development of Dengue virus inhibitors.

The early whole-blood transcriptional signature of dengue virus and features associated with progression to dengue shock syndrome in Vietnamese children and young adults

Epidemiological factors associated with dengue shock syndrome and mortality in hospitalized dengue patients in Ho Chi Minh City, Vietnam

Validation of an internally controlled one-step real-time multiplex RT-PCR assay for the detection and quantitation of dengue virus RNA in plasma

P304

1442-1450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/INFDIS/JIS470

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

207

http://www.w3.org/2001/XMLSchema#string

P50

Cameron P. Simmons

Martin L. Hibberd

P577

2012-07-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229161591

http://www.w3.org/2001/XMLSchema#string

P698

22807519

http://www.w3.org/2001/XMLSchema#string

P921

P932

3610419

http://www.w3.org/2001/XMLSchema#string